Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001641172-25-021610
Filing Date
2025-07-31
Accepted
2025-07-30 20:31:58
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-1/A forms-1a.htm S-1/A 1512866
2 EX-5.1 ex5-1.htm EX-5.1 13121
3 EX-23.1 ex23-1.htm EX-23.1 4315
4 EX-23.2 ex23-2.htm EX-23.2 4941
5 GRAPHIC formdrs_001.jpg GRAPHIC 15567
6 GRAPHIC forms-1fin_001.jpg GRAPHIC 40816
7 GRAPHIC forms-1fin_002.jpg GRAPHIC 2471
8 GRAPHIC ex5-1_001.jpg GRAPHIC 10144
9 GRAPHIC ex_23-1.jpg GRAPHIC 7086
  Complete submission text file 0001641172-25-021610.txt   1641888
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-288911 | Film No.: 251168895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)